Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
Clinical trial NCT03930732 · COMPLETED
Trial details
- NCT number
- NCT03930732
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2023-02-08
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.